Access cutting-edge leiomyosarcoma treatment through this clinical trial at a research site in St Louis. Study-provided care at no cost to qualified participants.
Access leiomyosarcoma specialists in St Louis at no cost
This study follows strict safety protocols and ethical guidelines
All study-related leiomyosarcoma treatment provided free
The present study is an open-label, randomized, controlled, two-arm multi-center study of the efficacy of L19TNF treatment in combination with doxorubicin versus doxorubicin alone in metastatic leiomyosarcoma patients.
Sponsor: Philogen S.p.A.
Check if you qualify for this leiomyosarcoma clinical trial in St Louis, MO
If you're searching for leiomyosarcoma treatment options in St Louis, MO, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our St Louis research site is actively enrolling participants for this clinical trial. You'll receive care from experienced leiomyosarcoma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.